Poxel SA raises €17.7m through capital increase
The gross proceeds of this reserved offering of about €17.69m will be used to "accelerate the development of Poxel’s clinical compounds PXL770...
S-Protein: Glycosylation pattern revealed
Using high-resolution mass spectrometry, researchers at the University of Southampton have mapped glycan-processing states of the spike protein...
Abivax bags €36m fund for COVID-19 programme
The funding led by by BPI France consists of a €20.1m grant and €15.9m loan refundable upon success of the company’s miR-AGE Phase II/III clinical...
Hyloris Pharmaceuticals prepared to go public
Reformulation specialist Hyloris Pharmaceuticals SA wants to go public on the regulated market of Euronext Brussels. The company reformulates...
COVID-19: Solnatide approved for compassionate use
The more COVID-19 patients reach advanced disease stages according to the eight-level WHO disease scale, the more important it becomes to treat...
Bacterial colonisation differs by tumour type
An international research team from Israel, the US, Italy, and the Netherlands profiled the microbiomes of more than 1,500 individual tumours across...
First drug found to reduce COVID-19-mortality
According to Principal Investigator Peter Horby from the University of Oxford, the cheap immunomodulatory drug dexamethasone helped reducing...